EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prevalence of Potentially Inappropriate Apixaban Prescribing Within a Single‐Centre Tertiary Hospital

Katherine J Creeper iD, Grace Lenaghan, Aaron Stockwell, Matthew Schmidt, Katharine Ingram, Andrew C Stafford iD

Australasian Journal on Ageing · 2026-06 · 45 (2)

DOI: 10.1111/ajag.70166 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Australasian Journal on Ageing, online erschienen am 17.04.2026. Verfasst von Katherine J Creeper und 5 weiteren Autor:innen. Beteiligte Einrichtung: Haematology Department, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia. Hauptthemen laut MEDLINE: Tertiary Care Centers, Pyrazoles, Pyridones, Atrial Fibrillation. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Charlies Leukaemia and Lymphoma Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Apixaban is widely recommended as first line therapy for atrial fibrillation (AF) and venous thromboembolism (VTE). Despite the widespread availability of dosing guidelines, anecdotal evidence suggests clinicians do not routinely follow these recommendations. Inappropriate dose reduction is associated with suboptimal patient outcomes. This project aimed to review current prescribing practices of apixaban 2.5 mg against guidelines to identify potentially inappropriate prescribing.

Method

A single‐centre, retrospective review of all adult patients admitted to a large tertiary hospital in Perth, Australia, who were dispensed apixaban 2.5 mg between 1 January 2023 and 31 December 2024, was undertaken. Patients were identified via dispensing records. Demographics, indication, comorbidities, concurrent medications and laboratory data were collated. Each case was assessed against current guidelines to determine whether dosing was appropriate or potentially inappropriate. Data were analysed using quantitative statistics.

Results

A total of 303 patients were dispensed apixaban 2.5 mg in the audit period. Of these 178 (59%) were newly initiated. The mean age of the cohort was 79 years (standard deviation [SD] 12.6), with 49% female. Of the 128 patients (72%) newly initiated on apixaban 2.5 mg for non‐valvular AF, 53 (41%) patients received a potentially inappropriate dose. A further 19 patients (11% of the entire cohort) received a potentially inappropriately low dose for acute VTE treatment.

Conclusions

A significant proportion of patients initiated on apixaban 2.5 mg received potentially inappropriate doses. These findings highlight the need for targeted anticoagulation stewardship and clinician education to optimise patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tertiary Care CentersPyrazolesPyridonesAtrial FibrillationFactor Xa InhibitorsPractice Patterns, Physicians'Inappropriate PrescribingVenous ThromboembolismHumansFemaleRetrospective StudiesAgedMaleAged, 80 and overGuideline AdherencePrevalencePractice Guidelines as TopicRisk FactorsMiddle Aged

Stichwörter der Autor:innen

agedanticoagulantsatrial fibrillationdrug therapyvenous thromboembolism

Substanzen

apixabanPyrazolesPyridonesFactor Xa Inhibitors

Autor:innen und Institutionen

  • Haematology Department, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
  • Haematology Department, PathWest Laboratory Medicine, Nedlands, Western Australia, Australia.
  • Curtin Medical School, Curtin University, Bentley, Western Australia, Australia.
  • Pharmacy Department, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
  • Department of Geriatric Acute and Rehabilitation Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.

ORCID-Profile: Katherine J Creeper, Andrew C Stafford

Förderung

  • Charlies Leukaemia and Lymphoma Fund

Zitieren

APA

Creeper, K. J., Lenaghan, G., Stockwell, A., Schmidt, M., Ingram, K., & Stafford, A. C. (2026). Prevalence of Potentially Inappropriate Apixaban Prescribing Within a Single‐Centre Tertiary Hospital. Australasian Journal on Ageing, 45(2). https://doi.org/10.1111/ajag.70166

Vancouver

Creeper KJ, Lenaghan G, Stockwell A, Schmidt M, Ingram K, Stafford AC. Prevalence of Potentially Inappropriate Apixaban Prescribing Within a Single‐Centre Tertiary Hospital. Australasian Journal on Ageing. 2026;45(2). doi:10.1111/ajag.70166

BibTeX
@article{Creeper2026,
  author = {Creeper, Katherine J and Lenaghan, Grace and Stockwell, Aaron and Schmidt, Matthew and Ingram, Katharine and Stafford, Andrew C},
  title = {Prevalence of Potentially Inappropriate Apixaban Prescribing Within a Single‐Centre Tertiary Hospital},
  journal = {Australasian Journal on Ageing},
  year = {2026},
  volume = {45},
  number = {2},
  doi = {10.1111/ajag.70166}
}
Kostenlos starten →